Efficacy and safety of intravenous infusion of ibandronic acid in children with osteogenesis imperfecta

This is a conference abstract about a medical treatment (ibandronic acid infusion) for children with osteogenesis imperfecta, a genetic bone disorder. The document provides only a title and metadata with no actual content, findings, or data about the intervention or its effects.

Key points

Limitations

The document contains only a title and publication metadata with no abstract text, methods, results, or conclusions. It is impossible to assess the intervention's efficacy, safety, population studied, or any evidence of outcomes.